Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751 · see citing works

Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease

Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322 · see citing works

Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade.

Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267 · see citing works

A position statement on NAFLD/NASH based on the EASL 2009 special conference

Ratziu, V., Bellentani, S., Cortez‐Pinto, H., Day, C., & Marchesini, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.008 · Cited by 1,058 · see citing works

CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis

Leclercq, I. A., Farrell, G. C., Field, J., Bell, D., Gonzalez, F. J., & Robertson, G. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8814 · Cited by 763 · see citing works

Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease

Kumashiro, N., Erion, D. M., Zhang, D., Kahn, M., Beddow, S. A., Chu, X., Still, C. D., Gerhard, G. S., Han, X., Dziura, J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113359108 · Cited by 585 · see citing works

Administration of the potent PPARα agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice

Ip, E., Farrell, G., Hall, P., Robertson, G., & Leclercq, I. (2004) · Hepatology · doi:10.1002/hep.20170 · Cited by 383 · see citing works

Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity

Choi, C. S., Savage, D. B., Abu-Elheiga, L., Liu, Z.-X., Kim, S., Kulkarni, A., Distefano, A., Hwang, Y.-J., Reznick, R. M., Codella, R., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706794104 · Cited by 325 · see citing works

Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice

Neschen, S., Morino, K., Hammond, L. E., Zhang, D., Liu, Z.-X., Romanelli, A. J., Cline, G. W., Pongratz, R. L., Zhang, X.-M., Choi, C. S., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.06.006 · Cited by 261 · see citing works

Reversal of Hypertriglyceridemia, Fatty Liver Disease, and Insulin Resistance by a Liver-Targeted Mitochondrial Uncoupler

Perry, R. J., Kim, T.-H., Zhang, X., Lee, H., Pesta, D. H., Popov, V., Zhang, D., Rahimi, Y., Jurczak, M. J., Cline, G. W., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.004 · Cited by 230 · see citing works

Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis

Perry, R. J., Zhang, X., Zhang, D., Kumashiro, N., Camporez, J. P., Cline, G. W., Rothman, D. L., & Shulman, G. I. (2014) · Nature Medicine · doi:10.1038/nm.3579 · Cited by 193 · see citing works

Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance

Lee, H., Birkenfeld, A. L., Jornayvaz, F. R., Jurczak, M. J., Kanda, S., Popov, V., Frederick, D. W., Zhang, D., Guigni, B. A., Bharadwaj, K. G., et al. (2011) · Hepatology · doi:10.1002/hep.24571 · Cited by 134 · see citing works

Prevention of paclitaxel‐induced peripheral neuropathy by lithium pretreatment

Mo, M., Erdélyi, I., Szigeti‐Buck, K., Benbow, J. H., & Ehrlich, B. E. (2012) · The FASEB Journal · doi:10.1096/fj.12-214643 · Cited by 101 · see citing works

Contributions of net hepatic glycogenolysis and gluconeogenesis to glucose production in cirrhosis

Petersen, K. F., Krššák, M., Navarro, V., Chandramouli, V., Hundal, R. S., Schumann, W. C., Landau, B. R., & Shulman, G. I. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.3.e529 · Cited by 96 · see citing works

The Role of the Carbohydrate Response Element-Binding Protein in Male Fructose-Fed Rats

Erion, D. M., Popov, V., Hsiao, J. J., Vatner, D. F., Mitchell, K. A., Yonemitsu, S., Nagai, Y., Kahn, M., Gillum, M. P., Dong, J., et al. (2012) · Endocrinology · doi:10.1210/en.2012-1725 · Cited by 84 · see citing works

An assessment of methods for measurement of glycogen synthetase activity including a new direct one-step assay

Passonneau, J. V., & Rottenberg, D. A. (1973) · Analytical Biochemistry · doi:10.1016/0003-2697(73)90510-1 · Cited by 36 · see citing works

All-Trans-Retinoic Acid Improves Cholestasis in α-Naphthylisothiocyanate–Treated Rats and Mdr2−/− Mice

Cai, S.-Y., Mennone, A., Soroka, C. J., & Boyer, J. L. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.209353 · Cited by 36 · see citing works

Mechanisms of NAFLD development and therapeutic strategies

Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354 · see citing works

Mechanisms of Insulin Action and Insulin Resistance

Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028 · see citing works

The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux

Samuel, V. T., & Shulman, G. I. (2016) · Journal of Clinical Investigation · doi:10.1172/jci77812 · Cited by 1,484 · see citing works

Insulin action and resistance in obesity and type 2 diabetes

Czech, M. P. (2017) · Nature Medicine · doi:10.1038/nm.4350 · Cited by 1,258 · see citing works

Mitochondrial dysfunction: mechanisms and advances in therapy

Yao, Z., Li, H., Liao, P., Chen, L., Pan, Y., Zheng, Y., Zhang, C., Liu, D., Zheng, M., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01839-8 · Cited by 1,274 · see citing works

Regulation of hepatic glucose metabolism in health and disease

Petersen, M. C., Vatner, D. F., & Shulman, G. I. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.80 · Cited by 1,131 · see citing works

Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents

Ryu, D., Mouchiroud, L., Andreux, P. A., Katsyuba, E., Moullan, N., Nicolet-dit-Félix, A. A., Williams, E. G., Jha, P., Lo Sasso, G., Huzard, D., et al. (2016) · Nature Medicine · doi:10.1038/nm.4132 · Cited by 1,105 · see citing works

Anti-obesity drug discovery: advances and challenges

Müller, T. D., Blüher, M., Tschöp, M. H., & DiMarchi, R. D. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00337-8 · Cited by 1,021 · see citing works

NAFLD and diabetes mellitus

Tilg, H., Moschen, A. R., & Roden, M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.147 · Cited by 1,002 · see citing works

Mitochondrial and metabolic dysfunction in ageing and age-related diseases

Amorim, J. A., Coppotelli, G., Rolo, A. P., Palmeira, C. M., Ross, J. M., & Sinclair, D. A. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00626-7 · Cited by 990 · see citing works

Mitochondria as a therapeutic target for common pathologies

Murphy, M. P., & Hartley, R. C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.174 · Cited by 832 · see citing works

Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases

Samuel, V. T., & Shulman, G. I. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.002 · Cited by 745 · see citing works

AMP-activated protein kinase: the current landscape for drug development

Steinberg, G. R., & Carling, D. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0019-2 · Cited by 757 · see citing works

Targeting adipose tissue in the treatment of obesity-associated diabetes

Kusminski, C. M., Bickel, P. E., & Scherer, P. E. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.75 · Cited by 678 · see citing works

Recent insights into the pathogenesis of nonalcoholic fatty liver disease

Arab, J. P., Arrese, M., & Trauner, M. (2018) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043617 · Cited by 573 · see citing works

Treatment of nonalcoholic fatty liver disease: role of AMPK

Smith, B. K., Marcinko, K., Desjardins, E. M., Lally, J., Ford, R. J., & Steinberg, G. R. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00225.2016 · Cited by 502 · see citing works

Mitochondrial Uncoupling: A Key Controller of Biological Processes in Physiology and Diseases

Demine, S., Renard, P., & Arnould, T. (2019) · Cells · doi:10.3390/cells8080795 · Cited by 476 · see citing works

Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH

Pierantonelli, I., & Svegliati‐Baroni, G. (2018) · Transplantation · doi:10.1097/tp.0000000000002480 · Cited by 459 · see citing works

Mitochondrial Dysfunction and Myocardial Ischemia-Reperfusion: Implications for Novel Therapies

Lesnefsky, E. J., Chen, Q., Tandler, B., & Hoppel, C. L. (2016) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103335 · Cited by 443 · see citing works

Redox homeostasis: The Golden Mean of healthy living

Ursini, F., Maiorino, M., & Forman, H. J. (2016) · Redox Biology · doi:10.1016/j.redox.2016.01.010 · Cited by 418 · see citing works

Targeting hepatic glucose metabolism in the treatment of type 2 diabetes

Rines, A. K., Sharabi, K., Tavares, C. D. J., & Puigserver, P. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.151 · Cited by 380 · see citing works

Roles of diacylglycerols and ceramides in hepatic insulin resistance

Petersen, M. C., & Shulman, G. I. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.04.004 · Cited by 373 · see citing works

Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC

Grohmann, M., Wiede, F., Dodd, G. T., Gurzov, E. N., Ooi, G. J., Butt, T., Rasmiena, A. A., Kaur, S., Gulati, T., Goh, P. K., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.053 · Cited by 373 · see citing works

Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease

Azzu, V., Vacca, M., Virtue, S., Allison, M., & Vidal-Puig, A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.054 · Cited by 369 · see citing works

Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis

Chung, H. K., Ryu, D., Kim, K. S., Chang, J. Y., Kim, Y. K., Yi, H.-S., Kang, S. G., Choi, M. J., Lee, S. E., Jung, S.-B., et al. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201607110 · Cited by 357 · see citing works

Repairing mitochondrial dysfunction in disease

Sorrentino, V., Menzies, K. J., & Auwerx, J. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104908 · Cited by 337 · see citing works

Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies

Sunny, N. E., Bril, F., & Cusi, K. J. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.11.006 · Cited by 321 · see citing works

A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease

Chen, Z., Yu, R., Xiong, Y., Du, F.-T., & Zhu, S. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0572-9 · Cited by 319 · see citing works

Hepatic glucose and lipid metabolism

Jones, J. G. (2016) · Diabetologia · doi:10.1007/s00125-016-3940-5 · Cited by 297 · see citing works

Treatment of type 2 diabetes: challenges, hopes, and anticipated successes

Nauck, M. A., Wefers, J., & Meier, J. J. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00113-3 · Cited by 300 · see citing works

Brown and beige fat: Molecular parts of a thermogenic machine

Cohen, P., & Spiegelman, B. M. (2015) · Diabetes · doi:10.2337/db15-0318 · Cited by 259 · see citing works

Hepatic Mitochondrial Pyruvate Carrier 1 Is Required for Efficient Regulation of Gluconeogenesis and Whole-Body Glucose Homeostasis

Gray, L. R., Sultana, M. R., Rauckhorst, A. J., Oonthonpan, L., Tompkins, S. C., Sharma, A., Fu, X., Miao, R., Pewa, A. D., Brown, K., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.027 · Cited by 217 · see citing works

Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy

Zheng, Y., Wang, S., Wu, J., & Wang, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04367-1 · Cited by 192 · see citing works

Use the Protonmotive Force: Mitochondrial Uncoupling and Reactive Oxygen Species

Berry, B. J., Trewin, A. J., Amitrano, A. M., Kim, M., & Wojtovich, A. P. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.03.025 · Cited by 175 · see citing works

Antiinfectives targeting enzymes and the proton motive force

Feng, X., Zhu, W., Schurig-Briccio, L. A., Lindert, S., Shoen, C. M., Hitchings, R., Li, J., Wang, Y., Baig, N., Zhou, T. H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521988112 · Cited by 173 · see citing works

Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis

Jian, C., Fu, J., Cheng, X., Shen, L., Ji, Y., Wang, X., Pan, S., Tian, H., Tian, S., Liao, R., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.011 · Cited by 172 · see citing works

A Membrane-Bound Diacylglycerol Species Induces PKCϵ-Mediated Hepatic Insulin Resistance

Lyu, K., Zhang, Y., Zhang, D., Kahn, M., ter Horst, K. W., Rodrigues, M. R. D. S., Gaspar, R. C., Hirabara, S. M., Luukkonen, P. K., Lee, S., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.08.001 · Cited by 173 · see citing works

GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)

Alkhouri, N., Lawitz, E., Noureddin, M., DeFronzo, R., & Shulman, G. I. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1668374 · Cited by 162 · see citing works

Glucose-6 Phosphate, a Central Hub for Liver Carbohydrate Metabolism

Rajas, F., Gautier‐Stein, A., & Mithieux, G. (2019) · Metabolites · doi:10.3390/metabo9120282 · Cited by 159 · see citing works

Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease

Schumann, T., König, J., Henke, C., Willmes, D. M., Bornstein, S. R., Jordan, J., Fromm, M. F., & Birkenfeld, A. L. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.015735 · Cited by 152 · see citing works

Metabolic liver disease in diabetes – From mechanisms to clinical trials

Dewidar, B., KAHL, S., Pafili, K., & Roden, M. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154299 · Cited by 160 · see citing works

Insulin Resistance and Mitochondrial Dysfunction

González-Franquesa, A., & Patti, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55330-6_25 · Cited by 154 · see citing works

Of mice and men – environmental temperature, body temperature, and treatment of obesity

Reitman, M. L. (2018) · FEBS Letters · doi:10.1002/1873-3468.13070 · Cited by 155 · see citing works

Small Molecule Mitochondrial Uncouplers and Their Therapeutic Potential

Childress, E. S., Alexopoulos, S. J., Hoehn, K. L., & Santos, W. L. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01182 · Cited by 144 · see citing works

Mitochondrial uncouplers induce proton leak by activating AAC and UCP1

Bertholet, A. M., Natale, A. M., Bisignano, P., Suzuki, J., Fedorenko, A., Hamilton, J., Brustovetsky, T., Kazak, L., Garrity, R., Chouchani, E. T., et al. (2022) · Nature · doi:10.1038/s41586-022-04747-5 · Cited by 142 · see citing works

Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions

Cusi, K. J. (2016) · Diabetologia · doi:10.1007/s00125-016-3952-1 · Cited by 139 · see citing works

Mitochondrial uncoupler BAM15 reverses diet-induced obesity and insulin resistance in mice

Alexopoulos, S. J., Chen, S.-Y., Brandon, A. E., Salamoun, J. M., Byrne, F. L., Garcia, C. J., Beretta, M., Olzomer, E. M., Shah, D. P., Philp, A. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16298-2 · Cited by 137 · see citing works

The Multifaceted Roles of Adipose Tissue—Therapeutic Targets for Diabetes and Beyond: The 2015 Banting Lecture

Scherer, P. E. (2016) · Diabetes · doi:10.2337/db16-0339 · Cited by 133 · see citing works

Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy

Hu, M., Wang, Y., Xu, L., An, S., Tang, Y., Zhou, X., Li, J., Liu, R., & Huang, L. (2019) · Nature Communications · doi:10.1038/s41467-019-10893-8 · Cited by 130 · see citing works

Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?

Ciaula, A. D., Passarella, S., Shanmugam, H., Noviello, M., Bonfrate, L., Wang, D. Q. ‐., & Portincasa, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105375 · Cited by 133 · see citing works

Novel Noninvasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy

Angelidi, A. M., Belanger, M. J., Kokkinos, A. D., Koliaki, C. C., & Mantzoros, C. S. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab034 · Cited by 133 · see citing works

Role of mitochondria in liver metabolic health and diseases

Morio, B., Panthu, B., Bassot, A., & Rieusset, J. (2020) · Cell Calcium · doi:10.1016/j.ceca.2020.102336 · Cited by 130 · see citing works

Sirtuins and nonalcoholic fatty liver disease

Nassir, F., & Ibdah, J. A. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i46.10084 · Cited by 126 · see citing works

Exploring the therapeutic potential of mitochondrial uncouplers in cancer

Shrestha, R., Johnson, E., & Byrne, F. L. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101222 · Cited by 125 · see citing works

Potential Nexus of Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Insulin Resistance Between Hepatic and Peripheral Tissues

Mu, W., Cheng, X., Liu, Y., Lv, Q., Gao-lin, L., Zhang, J.-G., & Li, X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01566 · Cited by 125 · see citing works

Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease

Lee, J., Park, J.-S., & Roh, Y. S. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01178-1 · Cited by 119 · see citing works

SGLT2 inhibition slows tumor growth in mice by reversing hyperinsulinemia

Nasiri, A. R., Rodrigues, M. R. D. S., Li, Z., Leitner, B. P., & Perry, R. J. (2019) · Cancer & Metabolism · doi:10.1186/s40170-019-0203-1 · Cited by 116 · see citing works

Mitochondria Related Cell Death Modalities and Disease

Tian, C., Liu, Y., Li, Z., Zhu, P., & Zhao, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.832356 · Cited by 113 · see citing works

Opportunities and challenges in the therapeutic activation of human energy expenditure and thermogenesis to manage obesity

Chen, K. Y., Brychta, R. J., Sater, Z. A., Cassimatis, T. M., Cero, C., Fletcher, L. A., Israni, N. S., Johnson, J. W., Lea, H. J., Linderman, J. D., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.007363 · Cited by 116 · see citing works

Postprandial hyperglycemia and postprandial hypertriglyceridemia in type 2 diabetes

Hiyoshi, T., Fujiwara, M., & Zemin, Y. (2018) · Journal of Biomedical Research · doi:10.7555/jbr.31.20160164 · Cited by 110 · see citing works

Assessing the Mitochondrial Membrane Potential in Cells and In Vivo using Targeted Click Chemistry and Mass Spectrometry

Logan, A., Pell, V. R., Shaffer, K. J., Evans, C., Stanley, N., Robb, E. L., Prime, T. A., Chouchani, E. T., Cochemé, H. M., Fearnley, I. M., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.11.014 · Cited by 107 · see citing works

Mitochondrial oxidative function in NAFLD: Friend or foe?

Shum, M., Ngo, J., Shirihai, O. S., & Liesa, M. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101134 · Cited by 107 · see citing works

2,4 Dinitrophenol as Medicine

Geisler, J. G. (2019) · Cells · doi:10.3390/cells8030280 · Cited by 104 · see citing works

Fatty acid oxidation is required for active and quiescent brown adipose tissue maintenance and thermogenic programing

Gonzalez-Hurtado, E., Lee, J., Choi, J., & Wolfgang, M. J. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.11.004 · Cited by 102 · see citing works

Mechanisms underlying UCP1 dependent and independent adipocyte thermogenesis

Chang, S., Song, N., Choi, J. H., Yun, U. J., & Park, K. W. (2018) · Obesity Reviews · doi:10.1111/obr.12796 · Cited by 104 · see citing works

DNP, mitochondrial uncoupling, and neuroprotection: A little dab'll do ya

Geisler, J. G., Marosi, K., Halpern, J., & Mattson, M. P. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.08.001 · Cited by 103 · see citing works

Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH

Goedeke, L., & Shulman, G. I. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101178 · Cited by 97 · see citing works

BAM15‐mediated mitochondrial uncoupling protects against obesity and improves glycemic control

Axelrod, C. L., King, W. T., Davuluri, G., Noland, R. C., Hall, J., Hull, M., Dantas, W. S., Zunica, E. R., Alexopoulos, S. J., Hoehn, K. L., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012088 · Cited by 89 · see citing works

Mitochondria-Centric Review of Polyphenol Bioactivity in Cancer Models

Stevens, J. F., Revel, J. S., & Maier, C. S. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7404 · Cited by 92 · see citing works

Mitochondrial H + Leak and Thermogenesis

Bertholet, A. M., & Kirichok, Y. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034405 · Cited by 92 · see citing works

SQR mediates therapeutic effects of H 2 S by targeting mitochondrial electron transport to induce mitochondrial uncoupling

Jia, J., Wang, Z., Zhang, M., Huang, C., Song, Y., Xu, F., Zhang, J., Li, J., He, M., Li, Y., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz5752 · Cited by 88 · see citing works

Mitochondrial oxidative injury: a key player in nonalcoholic fatty liver disease

Dornas, W. C., & Schuppan, D. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00121.2020 · Cited by 90 · see citing works

DJ-1 links muscle ROS production with metabolic reprogramming and systemic energy homeostasis in mice

Shi, S. Y., Lu, S.-Y., Sivasubramaniyam, T., Revelo, X. S., Cai, E. P., Luk, C. T., Schroer, S. A., Patel, P., Kim, R. H., Bombardier, É., et al. (2015) · Nature Communications · doi:10.1038/ncomms8415 · Cited by 86 · see citing works

Salsalate (Salicylate) Uncouples Mitochondria, Improves Glucose Homeostasis, and Reduces Liver Lipids Independent of AMPK-β1

Smith, B. K., Ford, R. J., Desjardins, E. M., Green, A. E., Hughes, M. C., Houde, V. P., Day, E. A., Marcinko, K., Crane, J. D., Mottillo, E. P., et al. (2016) · Diabetes · doi:10.2337/db16-0564 · Cited by 79 · see citing works

Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes

Goedeke, L., Perry, R. J., & Shulman, G. I. (2019) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104727 · Cited by 76 · see citing works

The intersection of nonalcoholic fatty liver disease and obesity

Baidal, J. W., & Lavine, J. E. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad8390 · Cited by 74 · see citing works

Mitochondrial-Targeted Catalase Protects Against High-Fat Diet–Induced Muscle Insulin Resistance by Decreasing Intramuscular Lipid Accumulation

Lee, H.-Y., Lee, J. S., Alves, T., Ladiges, W., Rabinovitch, P. S., Jurczak, M. J., Choi, C. S., Shulman, G. I., & Samuel, V. T. (2017) · Diabetes · doi:10.2337/db16-1334 · Cited by 66 · see citing works

Hungry for your alanine: when liver depends on muscle proteolysis

Sarabhai, T., & Roden, M. (2019) · Journal of Clinical Investigation · doi:10.1172/jci131931 · Cited by 74 · see citing works

Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer

Kaffe, E., Magkrioti, C., & Aidinis, V. (2019) · Cancers · doi:10.3390/cancers11111626 · Cited by 73 · see citing works

Mechanism of insulin resistance in obesity: a role of ATP

Ye, J. (2021) · Frontiers of Medicine · doi:10.1007/s11684-021-0862-5 · Cited by 70 · see citing works

Structure–activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposure

Mook, R. A., Wang, J., Ren, X.-R., Chen, M., Spasojević, I., Barak, L. S., Lyerly, H. K., & Chen, W. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.07.001 · Cited by 69 · see citing works

Mitochondrial pathways in human health and aging

Bornstein, R., González, B., & Johnson, S. C. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.07.007 · Cited by 70 · see citing works

Fifty Years of Research on Protonophores: Mitochondrial Uncoupling As a Basis for Therapeutic Action

Kotova, Е. А., & Antonenko, Y. N. (2022) · Acta Naturae · doi:10.32607/actanaturae.11610 · Cited by 68 · see citing works

Hydroxytyrosol Attenuates Hepatic Fat Accumulation via Activating Mitochondrial Biogenesis and Autophagy through the AMPK Pathway

Dong, Y., Li, L., Espe, M., Lu, K., & Rahimnejad, S. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c03310 · Cited by 66 · see citing works

Mechanism by which arylamine N -acetyltransferase 1 ablation causes insulin resistance in mice

Camporez, J. P., Wang, Y., Faarkrog, K., Chukijrungroat, N., Petersen, K. F., & Shulman, G. I. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716990115 · Cited by 67 · see citing works

Controlled-release mitochondrial protonophore (CRMP) reverses dyslipidemia and hepatic steatosis in dysmetabolic nonhuman primates

Goedeke, L., Peng, L., Montalvo-Romeral, V., Butrico, G. M., Dufour, S., Zhang, X., Perry, R. J., Cline, G. W., Kievit, P., Chng, K., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aay0284 · Cited by 65 · see citing works

Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies

Zhang, C., Zhou, B.-G., Sheng, J., Chen, Y., Cao, Y.-Q., & Chen, C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104984 · Cited by 62 · see citing works

Mitochondrial uncoupling protein 1 antagonizes atherosclerosis by blocking NLRP3 inflammasome–dependent interleukin-1β production

Gu, P., Hui, X. H., Zheng, Q., Gao, Y., Jin, L., Jiang, W., Zhou, C., Liu, T., Huang, Y., Liu, Q., et al. (2021) · Science Advances · doi:10.1126/sciadv.abl4024 · Cited by 61 · see citing works

Discovery of a potent allosteric activator of DGKQ that ameliorates obesity-induced insulin resistance via the sn-1,2-DAG-PKCε signaling axis

Zheng, Z., Xu, Y.-Y., Liu, W., Zhang, Y., Zhang, C., Liu, H.-L., Zhang, X., Liu, R., Zhang, Y., Shi, M.-Y., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.012 · Cited by 61 · see citing works

Mitochondria- and NOX4-dependent antioxidant defense mitigates progression to nonalcoholic steatohepatitis in obesity

Greatorex, S., Kaur, S., Xirouchaki, C. E., Goh, P. K., Wiede, F., Genders, A., Tran, M., Jia, Y., Raajendiran, A., Brown, W., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci162533 · Cited by 50 · see citing works

Non-invasive assessment of hepatic mitochondrial metabolism by positional isotopomer NMR tracer analysis (PINTA)

Perry, R. J., Peng, L., Cline, G. W., Butrico, G. M., Wang, Y., Zhang, X., Rothman, D. L., Petersen, K. F., & Shulman, G. I. (2017) · Nature Communications · doi:10.1038/s41467-017-01143-w · Cited by 61 · see citing works

Liver-targeted Nano-MitoPBN normalizes glucose metabolism by improving mitochondrial redox balance

Wu, M., Liao, L., Jiang, L., Zhang, C., Gao, H., Qiao, L., Liu, S., & Shi, D. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119457 · Cited by 59 · see citing works

Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH)

Min-DeBartolo, J. H., Schlerman, F. J., Akare, S., Wang, J., McMahon, J. B., Zhan, Y., Syed, J., He, W., Zhang, B., & Martinez, R. V. P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226854 · Cited by 62 · see citing works

Combatting type 2 diabetes by turning up the heat

Schrauwen, P., & Lichtenbelt, W. D. V. M. (2016) · Diabetologia · doi:10.1007/s00125-016-4068-3 · Cited by 59 · see citing works

Mitochondrial uncoupling prodrug improves tissue sparing, cognitive outcome, and mitochondrial bioenergetics after traumatic brain injury in male mice

Hubbard, W. B., Harwood, C. L., Geisler, J. G., Vekaria, H. J., & Sullivan, P. G. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24271 · Cited by 58 · see citing works

Cardiolipin content controls mitochondrial coupling and energetic efficiency in muscle

Prola, A., Blondelle, J., Vandestienne, A., Piquereau, J., Denis, R., Guyot, S., Chauvin, H., Mourier, A., Maurer, M., Henry, C., et al. (2021) · Science Advances · doi:10.1126/sciadv.abd6322 · Cited by 58 · see citing works

Reprogramming of Hepatic Metabolism and Microenvironment in Nonalcoholic Steatohepatitis

Rui, L., & Lin, J. D. (2022) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-062220-105200 · Cited by 56 · see citing works

Conformational switching within dynamic oligomers underpins toxic gain-of-function by diabetes-associated amyloid

Birol, M., Kumar, S., Rhoades, E. R., & Miranker, A. D. (2018) · Nature Communications · doi:10.1038/s41467-018-03651-9 · Cited by 56 · see citing works

Uncoupling Hepatic Oxidative Phosphorylation Reduces Tumor Growth in Two Murine Models of Colon Cancer

Wang, Y., Nasiri, A. R., Damsky, W., Perry, C. J., Zhang, X., Rabin-Court, A., Pollak, M., Shulman, G. I., & Perry, R. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.008 · Cited by 57 · see citing works

Mitochondrial uncoupler carbonyl cyanide m‐chlorophenylhydrazone induces vasorelaxation without involving K_ATPchannel activation in smooth muscle cells of arteries

Zhang, Y., Shen, X., Xiao, X., Liu, M., Li, S., Yan, J., Jin, J., Gao, J., Zhen, C., Hu, N., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13578 · Cited by 55 · see citing works

Sustained-release mitochondrial protonophore reverses nonalcoholic fatty liver disease in rats

Wei, G., Song, X., Fu, Y., Gong, T., & Zhang, Q. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.072 · Cited by 19 · see citing works

Proof of concept for a new type 2 diabetes mellitus therapy

(2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.41

A controlled-release mitochondrial protonophore reverses hypertriglyceridemia, nonalcoholic steatohepatitis, and diabetes in lipodystrophic mice

Abulizi, A., Perry, R. J., Camporez, J. P. G., Jurczak, M. J., Petersen, K. F., Aspichueta, P., & Shulman, G. I. (2017) · The FASEB Journal · doi:10.1096/fj.201700001r · Cited by 41 · see citing works

19-OR: Controlled-Release Mitochondrial Protonophore (CRMP) Reverses Hypertriglyceridemia and Hepatic Steatosis in Dysmetabolic Nonhuman Primates

Goedeke, L., ROMERAL, V. M., Butrico, G. M., Kahn, M., Dufour, S., Zhang, X., Cline, G. W., Petersen, K. F., Chng, K., & Shulman, G. I. (2019) · Diabetes · doi:10.2337/db19-19-or

Reversal of Hypertriglyceridemia, Fatty Liver Disease, and Insulin Resistance by a Liver-Targeted Mitochondrial Uncoupler

Perry, R. J., Kim, T.-H., Zhang, X., Lee, H., Pesta, D. H., Popov, V., Zhang, D., Rahimi, Y., Jurczak, M. J., Cline, G. W., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.004 · Cited by 230 · see citing works